Fundz

Harbour BioMed Appoints Vivian Feng as Senior Vice President

PRIVATENov 05, 2026
New to company · from Fosun Pharma“Most recently, she served as General Manager of the Business Development Department at Fosun Pharma”

Position

Senior Vice President

Company

Harbour BioMed

Vivian Feng
WashingtonBiotechnologyTherapeuticsBiopharma

Description

Harbour BioMed announced the appointment of Vivian Feng as Senior Vice President, Head of External Collaboration. She will be responsible for leading the company's external collaboration strategy and will be based in Shanghai.

Who to call at Harbour BioMed, and when

A new leader at Harbour BioMed brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Harbour BioMed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Harbour BioMed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Harbour BioMed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Harbour BioMed

Location

Washington, United States

About

Harbour BioMed is a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Harbour BioMed changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Harbour BioMed's next move

Learn about Strategic plan

Harbour BioMed changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.